1. Home
  2. HLMN vs MYGN Comparison

HLMN vs MYGN Comparison

Compare HLMN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$9.16

Market Cap

1.7B

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$7.02

Market Cap

625.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
MYGN
Founded
1964
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
625.5M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
HLMN
MYGN
Price
$9.16
$7.02
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$12.20
$11.82
AVG Volume (30 Days)
939.6K
1.1M
Earning Date
11-04-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
388.43
N/A
EPS
0.19
N/A
Revenue
$1,536,647,000.00
$825,300,000.00
Revenue This Year
$7.97
$0.10
Revenue Next Year
$7.80
$5.28
P/E Ratio
$48.64
N/A
Revenue Growth
4.47
0.21
52 Week Low
$6.55
$3.76
52 Week High
$11.29
$15.47

Technical Indicators

Market Signals
Indicator
HLMN
MYGN
Relative Strength Index (RSI) 57.31 46.64
Support Level $8.57 $7.15
Resistance Level $9.43 $7.43
Average True Range (ATR) 0.26 0.30
MACD 0.08 -0.00
Stochastic Oscillator 73.35 11.44

Price Performance

Historical Comparison
HLMN
MYGN

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: